Form 4: CONMED Corp Director Martha Goldberg Aronson Reports Transactions

Director Martha Goldberg Aronson reports acquisition and disposal of CONMED Corp stock and derivative securities.

Summary

• Martha Goldberg Aronson, a director of CONMED Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 31, 2024, 302 shares of common stock were acquired through the vesting of restricted stock units (RSUs).
• Also on May 31, 2024, 302 RSUs were disposed of.
• Aronson also indirectly owns 2,000 shares of common stock through an IRA.
• On June 3, 2024, Aronson acquired 5,503 options to purchase common stock at a price of $77.18, exercisable from June 3, 2025, and expiring on June 3, 2034.
• Additionally, on June 3, 2024, Aronson acquired 479 RSUs, vesting on June 3, 2025.
• Following these transactions, Aronson directly owns 11,912 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports transactions without expressing opinions or providing forward-looking statements.

Positives

• The acquisition of stock options and RSUs by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions may influence investor sentiment regarding CONMED Corp's stock.

Key Dates